EMA shares lessons learned from biosimilars pilot

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropePreclinical studyQuality Assurance and ControlRegulatory Intelligence/Policy